Showing 1 - 20 results of 22 for search 'Roberto Iacovelli', query time: 0.04s
Refine Results
-
1
-
2
-
3
-
4
-
5
Prevalence of Prostate Cancer at Different Clinical Stages in Italy: Estimated Burden of Disease Based on a Modelling Study by Federico Spandonaro, Daniela D’Angela, Barbara Polistena, Paolo Bruzzi, Roberto Iacovelli, Irene Luccarini, Paola Stagni, Alessia Brigido
Published 2021-03-01
Article -
6
The Role of the Complement in Clear Cell Renal Carcinoma (ccRCC)—What Future Prospects Are There for Its Use in Clinical Practice? by Martina Panebianco, Chiara Ciccarese, Alessandro Strusi, Viria Beccia, Carmine Carbone, Antonio Agostini, Geny Piro, Giampaolo Tortora, Roberto Iacovelli
Published 2024-01-01
Article -
7
Chemotherapy or targeted therapy as second-line treatment of advanced gastric cancer. A systematic review and meta-analysis of published studies. by Roberto Iacovelli, Filippo Pietrantonio, Alessio Farcomeni, Claudia Maggi, Antonella Palazzo, Francesca Ricchini, Filippo de Braud, Maria Di Bartolomeo
Published 2014-01-01
Article -
8
-
9
-
10
Clear Cell carcinoma of the urinary bladder, A case report: Surgical and oncological management by Emanuele Corongiu, Pietro Grande, Emanuele Liberati, Roberto Iacovelli, Mostafà Amini, Paola Mascioli, Giorgio Pagliarella, Stefano Squillacciotti, Angelo Di Santo, Alessandra Zampelli, Flavio Forte, Valerio Olivieri
Published 2020-10-01
Article -
11
Gain of ALK gene copy number may predict lack of benefit from anti-EGFR treatment in patients with advanced colorectal cancer and RAS-RAF-PI3KCA wild-type status. by Filippo Pietrantonio, Claudia Maggi, Maria Di Bartolomeo, Maria Grazia Facciorusso, Federica Perrone, Adele Testi, Roberto Iacovelli, Rosalba Miceli, Ilaria Bossi, Giorgia Leone, Massimo Milione, Giuseppe Pelosi, Filippo de Braud
Published 2014-01-01
Article -
12
Is Systemic Immune-Inflammation Index a Real Non-Invasive Biomarker to Predict Oncological Outcomes in Patients Eligible for Radical Cystectomy? by Pierluigi Russo, Filippo Marino, Francesco Rossi, Francesco Pio Bizzarri, Mauro Ragonese, Francesco Dibitetto, Giovanni Battista Filomena, Denise Pires Marafon, Chiara Ciccarese, Roberto Iacovelli, Savio Domenico Pandolfo, Achille Aveta, Simone Cilio, Luigi Napolitano, Nazario Foschi
Published 2023-11-01
Article -
13
Comparison of PIV and Other Immune Inflammation Markers of Oncological and Survival Outcomes in Patients Undergoing Radical Cystectomy by Pierluigi Russo, Giuseppe Palermo, Roberto Iacovelli, Mauro Ragonese, Chiara Ciccarese, Giuseppe Maioriello, Fabrizio Fantasia, Francesco Pio Bizzarri, Filippo Marino, Koosha Moosavi, Domenico Nigro, Giovanni Battista Filomena, Filippo Gavi, Francesco Rossi, Francesco Pinto, Marco Racioppi, Nazario Foschi
Published 2024-02-01
Article -
14
Application of the Meet-URO score to metastatic renal cell carcinoma patients treated with second- and third-line cabozantinib by Sara Elena Rebuzzi, Luigi Cerbone, Alessio Signori, Matteo Santoni, Veronica Murianni, Ugo De Giorgi, Giuseppe Procopio, Camillo Porta, Michele Milella, Umberto Basso, Francesco Massari, Marco Maruzzo, Roberto Iacovelli, Nicola Battelli, Luca Carmisciano, Giuseppe Luigi Banna, Sebastiano Buti, Giuseppe Fornarini
Published 2022-02-01
Article -
15
Faecal microbiota transplantation for the treatment of diarrhoea induced by tyrosine-kinase inhibitors in patients with metastatic renal cell carcinoma by Gianluca Ianiro, Ernesto Rossi, Andrew M. Thomas, Giovanni Schinzari, Luca Masucci, Gianluca Quaranta, Carlo Romano Settanni, Loris Riccardo Lopetuso, Federica Armanini, Aitor Blanco-Miguez, Francesco Asnicar, Clarissa Consolandi, Roberto Iacovelli, Maurizio Sanguinetti, Giampaolo Tortora, Antonio Gasbarrini, Nicola Segata, Giovanni Cammarota
Published 2020-08-01
Article -
16
Pembrolizumab Plus Axitinib for Metastatic Papillary and Chromophobe Renal Cell Carcinoma: NEMESIA (Non Clear MEtaStatic Renal Cell Carcinoma Pembrolizumab Axitinib) Study, a Subgr... by Marco Stellato, Sebastiano Buti, Marco Maruzzo, Melissa Bersanelli, Francesco Pierantoni, Ugo De Giorgi, Marilena Di Napoli, Roberto Iacovelli, Maria Giuseppa Vitale, Paola Ermacora, Andrea Malgeri, Brigida Anna Maiorano, Veronica Prati, Alessia Mennitto, Alessia Cavo, Matteo Santoni, Claudia Carella, Lucia Fratino, Giuseppe Procopio, Elena Verzoni, Daniele Santini
Published 2023-01-01
Article -
17
Targeting CD38 and PD-1 with isatuximab plus cemiplimab in patients with advanced solid malignancies: results from a phase I/II open-label, multicenter study by Rui Wang, Antoine Italiano, Shubham Pant, Johann De Bono, Todd M Bauer, Christophe Massard, Chia-Chi Lin, Roberto Iacovelli, Martin Gutierrez, Mansoor Saleh, Helen Lee, Gennaro Daniele, Paolo Andrea Zucali, Marielle Chiron, Bradley C Carthon, Robin Meng, Giovanni Abbadessa, Marcello Tucci, Wu-Chou Su, Alastair Greystoke, Ying-Chun Shen, Matteo Perrino, Yingwen Dong, Laure Loumagne, Lucie Lépine
Published 2022-01-01
Article -
18
U-CHANGE Project: a multidimensional consensus on how clinicians, patients and caregivers may approach together the new urothelial cancer scenario by Sergio Bracarda, Roberto Iacovelli, Valentina Baldazzi, Paolo Andrea Zucali, Paolo Andrea Zucali, Angela Gernone, Giario Natale Conti, Giovanni Pappagallo, Matteo Brunelli, Paolo Bruzzi, Edoardo Fiorini, Laura Magenta, Francesco Diomede, Federico Mereta, Irma D’Aria, Danilo Magliano, Monica Liberatori, Daniela Cantù, Davide Croce, Simone Eandi, Giorgio Lorenzo Colombo, Fulvio Ferrante, Emanuela Omodeo Salè, Andrea Marinozzi, Daniele Lenzi, Francesca Remiddi, Stefano Remiddi
Published 2023-07-01
Article -
19
Second line therapy with axitinib after only prior sunitinib in metastatic renal cell cancer: Italian multicenter real world SAX study final results by Gaetano Facchini, Sabrina Rossetti, Massimiliano Berretta, Carla Cavaliere, Sarah Scagliarini, Maria Giuseppa Vitale, Chiara Ciccarese, Giuseppe Di Lorenzo, Erica Palesandro, Vincenza Conteduca, Umberto Basso, Emanuele Naglieri, Azzurra Farnesi, Michele Aieta, Nicolò Borsellino, Leonardo La Torre, Gelsomina Iovane, Lucia Bonomi, Donatello Gasparro, Enrico Ricevuto, Michele De Tursi, Rocco De Vivo, Giovanni Lo Re, Francesco Grillone, Paolo Marchetti, Ferdinando De Vita, Claudio Scavelli, Claudio Sini, Salvatore Pisconti, Anna Crispo, Vittorio Gebbia, Antonio Maestri, Luca Galli, Ugo De Giorgi, Roberto Iacovelli, Carlo Buonerba, Giacomo Cartenì, Carmine D’Aniello
Published 2019-08-01
Article -
20
Inflammatory indices and clinical factors in metastatic renal cell carcinoma patients treated with nivolumab: the development of a novel prognostic score (Meet-URO 15 study) by Sara Elena Rebuzzi, Alessio Signori, Giuseppe Luigi Banna, Marco Maruzzo, Ugo De Giorgi, Paolo Pedrazzoli, Andrea Sbrana, Paolo Andrea Zucali, Cristina Masini, Emanuele Naglieri, Giuseppe Procopio, Sara Merler, Laura Tomasello, Lucia Fratino, Cinzia Baldessari, Riccardo Ricotta, Stefano Panni, Veronica Mollica, Mariella Sorarù, Matteo Santoni, Alessio Cortellini, Veronica Prati, Hector Josè Soto Parra, Marco Stellato, Francesco Atzori, Sandro Pignata, Carlo Messina, Marco Messina, Franco Morelli, Giuseppe Prati, Franco Nolè, Francesca Vignani, Alessia Cavo, Giandomenico Roviello, Francesco Pierantoni, Chiara Casadei, Melissa Bersanelli, Silvia Chiellino, Federico Paolieri, Matteo Perrino, Matteo Brunelli, Roberto Iacovelli, Camillo Porta, Sebastiano Buti, Giuseppe Fornarini
Published 2021-05-01
Article